Diabetic polyneuropathy treatment by benfotiamine.

[Article in Russian]

Sadekov RA, Danilov AB, Vein AM.

2nd Department of Internal Medicine,
Municipal St. John’s Hospital,
Budapest, Hungary.
Arzneimittelforschung. 1999 Mar;49(3):220-4.

Abstract

Efficiency of benfothiamine was studied in treatment of diabetic polyneuropathy in 14 patients with diabetes mellitus type II (1 dragee 3 times a day, within 6 weeks). After the course of treatment the intensity of pains was decreased according to visual analogous scale on the average from 8.2 to 2.3 scores, the indices of vibratory sensitivity improved significantly as well as the data of cardiovascular tests characterizing parasympathetic control of heart rhythm. Meanwhile latent periods of the evoked sympathetic potentials on arms and legs which were initially lengthened became significantly shorter. A clear-cut tendency was also found to increasing conduction rate for excitation through the motor nerves. The treatment resulted in the improvement of the condition in 93% of the cases. The conclusion was made about efficiency and safety of benfothiamine application in therapy of patients with diabetic polyneuropathy.